Brief: Phasebio Announces European Regulatory Update For Pb2452
11/02/2020 13:31
PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO ANNOUNCES EUROPEAN REGULATORY UPDATE FOR PB2452
* PHASEBIO PHARMACEUTICALS INC - PB2452 GRANTED PRIME
DESIGNATION
BY EUROPEAN MEDICINES AGENCY
* PHASEBIO PHARMACEUTICALS INC - PHASEBIO RECEIVES WRITTEN
SCIENTIFIC ADVICE CONFIRMING PB2452 CLINICAL DEVELOPMENT PLAN
Source text for Eikon: ID:nGNX7v7Q1r
Further company coverage: PHAS.O
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans